Q32 Bio (QTTB) Revenue Growth (3y) (2021 - 2023)
Q32 Bio (QTTB) Revenue Growth (3y) (2021 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -50.19% |
| Sep 30, 2023 | 48.56% |
| Jun 30, 2023 | 78.13% |
| Mar 31, 2023 | 71.13% |
| Dec 31, 2022 | 12.52% |
| Sep 30, 2022 | 22.06% |
| Jun 30, 2022 | 26.95% |
| Mar 31, 2022 | 43.75% |
| Dec 31, 2021 | -12.47% |
| Sep 30, 2021 | 1.54% |
| Jun 30, 2021 | 16.17% |
| Mar 31, 2021 | 196.08% |